Treatment of nosocomial meningitis due to a multidrug resistant Acinetobacter baumannii with intraventricular colistin.

Author: Al-AbdelyHail M, Al-KhaniAhmed, BukharyZakeya, MahmoodWafeeq

Paper Details 
Original Abstract of the Article :
We report a case of serious nosocomial meningitis due to a multidrug-resistant Acinetobacter baumannii in a 23-year-old woman who had a posterior fossa craniotomy with upper cervical laminectomy for excision of a meningioma at the level of foramen magnum. Post-operatively, she had neck pain with con...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/15900379

データ提供:米国国立医学図書館(NLM)

A Battle Against Multidrug-Resistant Meningitis

Meningitis, an inflammation of the membranes surrounding the brain and spinal cord, can be a life-threatening condition. The emergence of multidrug-resistant bacteria, like a persistent desert storm, has posed a significant challenge to the treatment of meningitis. This study reports a case of nosocomial meningitis caused by a multidrug-resistant Acinetobacter baumannii, highlighting the need for innovative treatment strategies.

Intraventricular Colistin: A Last Resort

The patient in this study failed to respond to conventional antibiotic therapies, but showed a positive response to intraventricular injections of colistin, a potent antibiotic. This case underscores the importance of considering alternative treatment options for multidrug-resistant infections.

A Call for Vigilance

This research emphasizes the ongoing challenge of multidrug-resistant infections and highlights the need for continued research and development of novel antimicrobial therapies.

Dr.Camel's Conclusion

This case study, like a battle in the desert, showcases the tenacity of multidrug-resistant bacteria. The researchers' use of intraventricular colistin serves as a reminder that even in the face of seemingly insurmountable challenges, there can be innovative solutions.

Date :
  1. Date Completed 2008-01-16
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

15900379

DOI: Digital Object Identifier

20040735'

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.